GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (XTER:PA8) » Definitions » Preferred Dividends

Paion Ag (XTER:PA8) Preferred Dividends : €0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Paion Ag's preferred dividends for the six months ended in Jun. 2023 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil.


Paion Ag Preferred Dividends Historical Data

The historical data trend for Paion Ag's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Preferred Dividends Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Paion Ag Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Paion Ag  (XTER:PA8) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag (XTER:PA8) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Executives
Gregor Siebert Board of Directors
Dr. James Neil Phillips Board of Directors

Paion Ag (XTER:PA8) Headlines

No Headlines